Abingworth’s Immune Design IMDZ Stock Holding History
Bought
Maintained
Sold
Other funds holding IMDZ
SAM
Abingworth's IMDZ Position: Q1 2019 in Review
Abingworth sold out of Immune Design (IMDZ) in Q1 2019, closing a stake of 352,300 shares — an estimated $458K sold.
Abingworth first reported a position in IMDZ in Q2 2016 and held it in 11 quarters. The position peaked at $3.65M in Q3 2017. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.
- Abingworth reported no remaining Immune Design position as of Q1 2019 after selling out during the quarter.
- Abingworth sold 352,300 Immune Design shares in Q1 2019, an estimated $458K.
- Abingworth first reported a position in Immune Design in Q2 2016 and held it in 11 quarters.
- Abingworth's Immune Design position peaked at $3.65M in Q3 2017.
- 68 funds tracked by Wall St. Rank held Immune Design as of Q1 2019.
Based on Abingworth's 13F filing for Q1 2019, filed 15 May 2019.